Table 1.

Biochemical panel over the course of treatment at our institute

Date	GH	IGF1
Normal range	0.4-10 μg/L (0.4–10 ng/mL)	12.94-31.25 nmol/L (99-239 μg/L)
June 1, 2021	6.67 μg/L (6.67 ng/mL)	H 89.42 nmol/L (H 684.0 μg/L)
December 15, 2021	5.99 μg/L (5.99 ng/mL)	H 89.16 nmol/L (H 682.0 μg/L)
April 28, 2022	2.60 μg/L (2.60 ng/mL)	H 58.96 nmol/L (H 451.0 μg/L)
June 26, 2022	2.91 μg/L (2.91 ng/mL)	H 58.96 nmol/L (H 451.0 μg/L)
October 10, 2022	1.24 μg/L (1.24 ng/mL)	H 50.46 nmol/L (H 386.0 μg/L)
April 16, 2023	—	52.69 nmol/L (H 403.0 μg/L)
September 3, 2023	3.71 μg/L (3.71 ng/mL)	14.12 nmol/L (108.0 μg/L)
May 6, 2024	6.65 ug/L (6.65 ng/mL)	29.15 nmol/L (223 µg/L)

Initiation of 40 mg pasireotide in August 2023.

Abbreviation: H, high.